Chemokine-based therapies for MS: how do we get there from here?

MLA

Kivisakk, P., et al. “Chemokine-Based Therapies for MS: How Do We Get There from Here?” Trends in Immunology, vol. 22, no. 11, Jan. 2001, pp. 591–93. EBSCOhost, https://doi.org/10.1016/S1471-4906(01)02056-7.

APA

Kivisakk, P., Trebst, C., Eckstein, D. J., Kerza-Kwiatecki, A. P., & Ransohoff, R. M. (2001). Chemokine-based therapies for MS: how do we get there from here? Trends in Immunology, 22(11), 591–593. https://doi.org/10.1016/S1471-4906(01)02056-7

Chicago

Kivisakk, P., C. Trebst, D. J. Eckstein, A. P. Kerza-Kwiatecki, and R. M. Ransohoff. 2001. “Chemokine-Based Therapies for MS: How Do We Get There from Here?” Trends in Immunology 22 (11): 591–93. doi:10.1016/S1471-4906(01)02056-7.